The company reported net sales of $248 million for the fourth quarter, an increase of $21.6 million from the same period last year. Full year net sales were reported as $918.5 million. Despite the growth, the company still under performed expectations due to high unemployment, flat Medicare pricing and reduction in Medicaid reimbursement, according to the release.
The company expects full year revenues for 2012 to reach $970 million to $990 million.
Related Articles on Orthopedic Device Companies:
Zimmer Introduces Chondrofix Osteochondral Allograft
DePuy Launches 6 New Orthopedic Devices
Amedica Names Eric Olson President & CEO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.